Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Vascular disease

Meta-regression of CIMT trials—data in, garbage out

Meta-regression of trials using carotid intima–media thickness (CIMT) as a surrogate end point leads to unreliable results owing to heterogeneity in methods, interventions, and outcomes of pooled trials. CIMT will continue to be a worthwhile surrogate trial end point supported by two decades of technical progress and clinical atherosclerosis research.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Greenland, P. et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 56, 2182–2199 (2010).

    Article  Google Scholar 

  2. Costanzo, P. et al. Does carotid intima–media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J. Am. Coll. Cardiol. 56, 2006–2020 (2010).

    Article  Google Scholar 

  3. Taylor, A. J. et al. Extended-release niacin or ezetimibe and carotid intima–media thickness. N. Engl. J. Med. 361, 2113–2122 (2009).

    CAS  Article  Google Scholar 

  4. Lorenz, M. W. et al. for the PROG-IMT Study Group. Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project. Am. Heart J. 159, 730–736e2 (2010).

    Article  Google Scholar 

  5. Smilde, T. J. et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 357, 577–581 (2001).

    CAS  Article  Google Scholar 

  6. Tendal, B. et al. Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study. BMJ 339, b3128 (2009).

    Article  Google Scholar 

  7. Goldberger, Z. D. et al. Are changes in carotid intima–media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis. Am. Heart J. 160, 701–714 (2010).

    Article  Google Scholar 

  8. LeLorier, J., Grégoire, G., Benhaddad, A., Lapierre, J. & Derderian, F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N. Engl. J. Med. 337, 536–542 (1997).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Allen J. Taylor.

Ethics declarations

Competing interests

A. J. Taylor is a consultant for Abbott. M. L. Bots and J. J. P. Kastelein declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Taylor, A., Bots, M. & Kastelein, J. Meta-regression of CIMT trials—data in, garbage out. Nat Rev Cardiol 8, 128–130 (2011).

Download citation

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing